Page last updated: 2024-11-02

pentobarbital and Autism

pentobarbital has been researched along with Autism in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Research Excerpts

ExcerptRelevanceReference
"Children ages 18-36 months with autism (group 1, n = 41) and children with no autistic behavior (group 2, n = 42) were sedated with a combination of pentobarbital and fentanyl per sedation service protocol."3.73Moderate sedation for MRI in young children with autism. ( Garrett, NT; Hazlett, HC; Piven, J; Ross, AK; Wilkerson, C, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ross, AK1
Hazlett, HC1
Garrett, NT1
Wilkerson, C1
Piven, J1

Other Studies

1 other study available for pentobarbital and Autism

ArticleYear
Moderate sedation for MRI in young children with autism.
    Pediatric radiology, 2005, Volume: 35, Issue:9

    Topics: Anesthetics, Intravenous; Autistic Disorder; Conscious Sedation; Female; Fentanyl; Humans; Hypnotics

2005